SK Life Science Labs
Zhenwu Li is an accomplished chemist currently serving as the Associate Director of Discovery Chemistry at Proteovant Therapeutics since November 2021, focusing on innovative protein degradation solutions for serious diseases. Prior experience includes roles as Principal Investigator, Senior Research Investigator, and Research Investigator at Incyte from March 2015 to November 2021. Zhenwu Li also held postdoctoral positions at Yale University and the University of Hawaii at Manoa, contributing to significant synthetic projects. Educational credentials include a Ph.D. in Organic Chemistry from the Shanghai Institute of Organic Chemistry and additional postdoctoral training at Yale University and the University of Hawaii at Manoa, alongside a Bachelor's degree in Chemistry from Nanjing University.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU